Talazoparib: Phase I data

Data from 19 evaluable patients with BRCA-mutated solid tumors or TNBC with no known BRCA mutation

Read the full 168 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE